CENTESSA PHARMACEUTICALS PLC Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus commercial paper. Period ending 2026-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus commercial paper / total assets. Period ending 2026-03-31..
Borrowing debt
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus commercial paper. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus commercial paper / total assets. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 110.44M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities |
| Total assets | 641.76M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | (m) | (m) | $110.44M | (m) | (m) | $641.76M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $110.09M | (m) | (m) | $687.50M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $109.82M | (m) | (m) | $448.30M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $109.55M | (m) | (m) | $492.13M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $109.25M | (m) | (m) | $527.85M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $108.94M | (m) | (m) | $576.80M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $75.70M | (m) | (m) | $609.72M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $76.50M | (m) | (m) | $398.85M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $76.80M | (m) | (m) | $328.17M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $75.70M | (m) | (m) | $360.25M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $74.00M | (m) | (m) | $377.36M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $73.30M | (m) | (m) | $392.92M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $71.60M | (m) | (m) | $403.86M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $69.80M | (m) | (m) | $444.31M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $68.20M | (m) | (m) | $479.36M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $67.40M | (m) | (m) | $521.05M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $74.80M | (m) | (m) | $582.19M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $75.70M | (m) | (m) | $629.63M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | $11.72M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.